Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).

Abstract

Edaravone was found to be associated with better neurological outcome at 3 months. Citicoline's role as a neuroprotective agent however remains controversial in acute ischaemic stroke.